XyloCor Therapeutics Funding: $108M Raised, Series B (2025)
XyloCor Therapeutics is based in Wayne. It has raised $108M in total funding. Latest round: Series B.
XyloCor Therapeutics funding overview
XyloCor Therapeutics is based in Wayne. XyloCor Therapeutics has raised $108M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2025. The round record for XyloCor Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Jeito Capital, EQT, Fountain Healthcare Partners, Lumira Ventures, Sofinnova Investments, Life Sciences Partners (LSP). 6 distinct backers are named across the disclosed rounds.
Frequently asked about XyloCor Therapeutics funding
How much has XyloCor Therapeutics raised?
XyloCor Therapeutics has raised $108M in total disclosed funding across the rounds on record.
Who has invested in XyloCor Therapeutics?
Jeito Capital, EQT, Fountain Healthcare Partners, Lumira Ventures, Sofinnova Investments, Life Sciences Partners (LSP) are named among the investors backing XyloCor Therapeutics.
What was the latest XyloCor Therapeutics funding round?
The most recent disclosed round is a Series B, announced in January 2025.
Where is XyloCor Therapeutics based?
XyloCor Therapeutics is based in Wayne.
When did XyloCor Therapeutics last raise?
The last disclosed XyloCor Therapeutics round closed in January 2025 at Series B.
We update the XyloCor Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Wayne and their backers are listed below.
